- Home
- Companies
- solomon islands
- disease progression
Show results for
Refine by
Disease Progression Suppliers Serving Solomon Islands
87 companies found
based inSt. Louis, MISSOURI (USA)
C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...
The PrecivityAD™ test is an innovative new blood test intended for use in patients with cognitive impairment. The test aims to help physicians better determine the presence or absence of amyloid plaques in the brain, a hallmark sign of ...
based inOakland, CALIFORNIA (USA)
Eko is your all-in-one screening and telemedicine solution, helping you detect cardiac conditions easier and provide timely care from anywhere. The ability to listen is the ability to care. Eko understands how important listening can be for ...
DUO is the first cardiac assessment tool that functions as an ECG and digital stethoscope, used to detect early signs of heart disease and facilitate more personalized care in any environment. DUO can be used with or without included ...
based in, NEW JERSEY (USA)
Diopsys, Inc. is the world leader in modern visual electrophysiology medical devices that help eye care professionals analyze the entire visual pathway for visual and neuro-visual disorders. The company provides both Visual Evoked Potential (VEP) ...
The Diopsys® ffERG (full field electroretinography) module includes several important protocols to help you detect disease early and manage patient care. Understanding how your patient is responding to treatment is important. Is ...
based inKiel, GERMANY
tiakis biotech AG (“tiakis”) – formerly Proteo Biotech AG - is the next generation preventive therapeutic technology company. We focus on our clinical-stage proprietary and pioneering tissue protective drug ...
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the ...
based inNewark, CALIFORNIA (USA)
ACD - a Bio-Techne brand, shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and ...
ACD's Professional Assay Services group has been developing RNAscope™ biomarker assays for our biopharma partners for a decade. Our biomarker assays have contributed to important clinical trial exploratory endpoints, enabled more accurate ...
based inMechelen, BELGIUM
Galapagos discovers, develops and commercializes small molecule medicines with novel modes of action. Our pipeline comprises discovery through to Phase 3 programs in inflammation, fibrosis, and other indications. Our first medicine is approved and ...
based inKontich, BELGIUM
Fluidda was founded in 2005, focusing on Computational Fluid Dynamics (CFD), a discipline used in the design of aircraft wings. Image processing of CT scans and flow simulations on patient-specific 3D models are combined to provide a unique ...
based inCopenhagen, DENMARK
Cmbio specializes in advancements in microbiome science and multi-omics research, primarily focused on human, animal, and planetary health. With a team of over 100 experts in microbiology, bioinformatics, metabolomics, molecular biology, and data ...
based inEdmonton, ALBERTA (CANADA)
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection. ...
Our lead product, ClarityDx Prostate® is designed to be a highly accurate test to assist in diagnosing clinically significant prostate cancer and improve prostate healthcare decisions. Validation of ClarityDX Prostate® is ongoing in a 2800 ...
based inAmsterdam, NETHERLANDS
Self-screen has a long history and track record in translational HPV related science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of HPV related cancer screening into routine practice. Our ...
based inTewksbury, MASSACHUSETTS (USA)
Cambridge Isotope Laboratories, Inc. (CIL) is the world’s leading producer of stable isotopes and stable isotope-labeled compounds. With over 400 employees and laboratories in four countries, CIL specializes in the process of labeling biochemical ...
based inCambridge, MASSACHUSETTS (USA)
TriNetX is the global health research network that connects the world of drug discovery and development from pharmaceutical company to study site, and investigator to patient by sharing real-world data to make clinical and observational research ...
Data sourced from the EHRs of U.S. healthcare organizations forms the foundation of this combined data asset, providing a rich clinical picture of patients from encounters with providers, lab results, procedures, medication orders, and genomics. ...
based inOxford, UNITED KINGDOM
As a leading global provider of diagnostic genomic solutions, our goal is to enable researchers and clinical decision makers to reach the right decisions for each patient, every time. The quality and innovation built into our products for NGS, ...
The P53 probe mix consists of a 161kb probe, labelled in red that covers the whole P53 (TP53) gene and the flanking regions. The probe mix also contains a control probe for the 17 centromere (D17Z1) that is labelled in ...
based inConcord, MASSACHUSETTS (USA)
At Adiso, we create medicines to treat inflammatory diseases, improving the lives of patients and their families. Current treatment paradigms are far too often either inadequate to halt disease progression or burden the patient with significant ...
based inParis, FRANCE
Qynapse, through QyScore, brings groundbreaking peace of mind to the global fight against CNS disease. Qyscore is a medical device software FDA-cleared – class II and CE-marked – class IIa (CE BSI). Qyscore is a medical device software FDA-cleared ...
The software is intended to be used by medical personnel or neuroimaging trained personnel to support diagnosis of central nervous system diseases. Available for research use only and protected by 3 patents, QyPredict has the ...
based inYardley, PENNSYLVANIA (USA)
MMIT, a Norstella company, focuses on enhancing market access for pharmaceutical companies by offering real-time data and insights as well as crucial commercial execution strategies. With decades of experience, MMIT has evolved from its origins as ...
MMIT and its parent company Norstella transform physician clinical notes, specialty consultations and other unstructured EMR notes into longitudinal, analytic-ready ...
based inFargo, NORTH DAKOTA (USA)
We provide high-quality plasmid DNA, proteins, enzymes, and other biologicals to help our partners achieve ground-breaking science throughout a variety of life science applications. From contract services to comprehensive solutions, we supply what ...
based inShanghai, CHINA
Focusing on the core raw materials of the life science industry, Yeasen Biotechnology (Shanghai) Co., Ltd. is a biotechnology company engaged in the research and development, production and sales of three major categories of biological reagents: ...
D-luciferin is a common substrate for Luciferase and is widely used throughout biotechnology, especially in vivo imaging Technology. The mechanism of action is that luciferin (substrate) can be oxidized to emit light in the presence of ATP and ...
based inParis, FRANCE
A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for ...
based inGoerlitz, GERMANY
Sysmex Partec is the newly formed collaboration between Partec, a worldwide leading pioneer, developer and manufacturer of flow cytometry systems and Sysmex Corporation, a leading international supplier of in vitro diagnostic products. Sysmex Partec ...
Highly sensitive down to 0.06 % MAF, Able to detect 6 MM with 95 % confidence across all mutations (absolute quantification), High flexibility of between 2-16 samples/run, Fast TAT (2 days), Convenient software. Plasma-SeqSensei (PSS) BC RUO Kit ...
